- Home
- ANGH vs OSRH Comparison
ANGH vs OSRH Comparison
Compare ANGH & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANGH | OSRH |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United Arab Emirates | United States |
| Employees | 186 | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.6M | 18.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ANGH | OSRH |
|---|---|---|
| Price | $2.68 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.9K | ★ 369.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.25 | $0.38 |
| 52 Week High | $7.05 | $4.33 |
Technical Indicators
Market Signals| Indicator | ANGH | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 48.88 | 33.41 |
| Support Level | $2.38 | $0.39 |
| Resistance Level | $3.01 | $0.76 |
| Average True Range (ATR) | 0.29 | 0.04 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 42.71 | 8.62 |
Price Performance
Historical ComparisonAbout ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.